IDH1 and brain neoplasm: In addition, KYNU expression was analyzed depending on the IDH mutation, which is known as a prognostic factor for brain tumor patients [52,53]; under this condition, the wildtype IDH status showed the higher KYNU expression, correlating with poor survival outcome in GBM patients.